Phase III Randomized, Double-blind Study to Assess the Efficacy and Safety of alpha-lipoic Acid Versus BK-C-0701 in Subjects With Diabetic Neuropathy.
Phase of Trial: Phase III
Latest Information Update: 24 Apr 2012
At a glance
- Drugs Thioctic acid (Primary)
- Indications Diabetic neuropathies
- Focus Therapeutic Use
- Sponsors Bukwang Pharmaceutical
- 24 Apr 2012 Actual end date Apr 2012 added as reported by ClinicalTrials.gov.
- 24 Apr 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 20 Dec 2010 New trial record